Given it looks like Obama has finally won the healthcare reform battle, how do people think it will change the US market for the pharma companies, insurers, providers etc?
Who is it good news for and who is it bad for?
I saw a tweet to the article below at Forbes.com which gives one summary of potential impact:
http://blogs.forbes....g-industrys-big-win/
The summary seems to be:
Uninsured patients - good news (unsurprising)
Pharma cos - good news, no price controls and potentially more patients
Insurers - a mixed bag but potentially bad news
It would be interesting to hear what others make of it though, so good question.
And what about insured the majority of insured patients - probably bad news for companies providing healthcare and those paying themselves as premiums rise! Obama has one heck of a job to sell this one to the people.
Interesting to see the fuss it has caused. For those of us working in the UK market, we've kind of got used to the idea that you can't keep pricing drugs up and up with little incremental benefit for the patient.
It had to happen sometime and the US will probably start to resemble the European markets in the way it deals with drug pricing.
ay1978 said
It had to happen sometime and the US will probably start to resemble the European markets in the way it deals with drug pricing.
If this happens then every US State will do it a different way! Part of the challenge in Europe is that we don't have a single way of dealing with drug pricing / market access.
Regardless of political affiliation, the obvious facts are that costs have continually increased over the last decade. How should the problem(s) be resolved? Is Obama really won the healthcare battle?
Phew! Talk about the million dollar question. No easy solution there IMO, but the US will start to look much more closely at cost benefit of drugs, irrespective of whether it is for government or private insurance schemes. One way or another it all filters back to the taxpayer and the economy.
I don't think it's possible to win the healthcare battle - people are getting older and that creates a massive healthcare burden. The more diseases we manage, the more news ones emerge with old age.
Sorry for the cheery thought.
I'm more interested in the knock-on effect it will have on global markets - any market researchers out there looking into this?
You must be logged in to post a reply.